Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

Background Systemic lupus erythematosus (SLE) is an autoimmune disease that typically
affects women aged 16–55 years. Cardiovascular disease (CVD) is a well-recognized …

The contribution of dyslipidemia and inflammation in atherosclerosis is well established.
Along with effective lipid-lowering treatments, the recent success of clinical trials with anti …

Systemic lupus erythematosus (SLE) carries a significant risk of cardiovascular disease
(CVD). The prevalence of premature CVD is especially noteworthy because it occurs in …

Background Atherosclerosis is the salient, underlying cause of cardiovascular diseases,
such as arrhythmia, coronary artery disease, cardiomyopathy, pulmonary embolism and …

Adaptive immune response plays an important role in atherogenesis. In atherosclerosis, the
proinflammatory immune response driven by Th1 is predominant but the anti-inflammatory …

Objectives Patients with SLE have increased cardiovascular mortality. Alterations in both
macro-and micro-circulation have been associated with cardiovascular disease. We sought …

Systemic lupus erythematosus is a chronic connective tissue disease associated with an
increased risk of premature atherosclerosis. It is estimated that approximately 10% of SLE …

Background: Atherosclerosis (AS) is a major risk factor for cardiovascular disease.
microRNAs play a key role in gene regulation in the formation and development of …

Objective To compare the prevalence of the main comorbidities in 2 large cohorts of patients
with primary Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE), with a focus …